Sort

Search

01/03/2026 Sex Differences in the Diagnosis and Management of Heart Failure Among Outpatients with Type 2 Diabetes
Gonzalez-Manzanares, R, Anguita-Gámez, M, Muñiz, J, Barrios, V, Gimeno-Orna, JA, Pérez, A, Rodríguez-Padial, L, Anguita, M. Sex Differences in the Diagnosis and Management of Heart Failure Among Outpatients with Type 2 Diabetes. JOURNAL OF WOMENS HEALTH. 2026; 35(3)DOI:10.1177/15409996251401741. PMID:41449991. IF:1.900(Q1/2D).
01/03/2026 Patient-reported outcomes and time to symptomatic progression from PAPILLON: amivantamab plus chemotherapy vs chemotherapy as first-line treatment of EGFR exon 20 insertion-mutated advanced NSCLC
Paz-Ares, L, Veillon, R, Majem, M, Zhou, CC, Tang, KJ, Kim, SW, Richardson, G, Girard, N, Sanborn, RE, Mansfield, AS, Park, K, Schuchard, J, Diels, J, Sermon, J, Bhattacharya, A, Lorenzini, P, Wortman-Vayn, H, Knoblauch, RE, Agrawal, T, Baig, M, Ono, A, Sabari, JK. Patient-reported outcomes and time to symptomatic progression from PAPILLON: amivantamab plus chemotherapy vs chemotherapy as first-line treatment of EGFR exon 20 insertion-mutated advanced NSCLC. LUNG CANCER. 2026; 213DOI:10.1016/j.lungcan.2025.108788. PMID:41671629. IF:4.400(Q1/2D).
01/03/2026 Urinary glucose tetrasaccharide tracks disease activity in late-onset Pompe disease
Dominguez-González, C, Iannucci, D, Clark, J, Martin-Jiménez, P, Hold, S, Oliva, P, Bischinger, A, Gallardo, E, Diaz-Manera, J. Urinary glucose tetrasaccharide tracks disease activity in late-onset Pompe disease. NEUROMUSCULAR DISORDERS. 2026; 60DOI:10.1016/j.nmd.2026.106359. PMID:41638029. IF:2.800(Q2/5D).
01/03/2026 Motor fluctuations in Parkinson's disease leave a distinct immune fingerprint in blood
Pérez-González, R, Vázquez-Oliver, A, Rivas-Asensio, E, Campolongo, A, Pons-Pons, G, Martínez-Horta, S, Pagonabarraga, J, Pascual-Sedano, B, Kulisevsky, J. Motor fluctuations in Parkinson's disease leave a distinct immune fingerprint in blood. PARKINSONISM & RELATED DISORDERS. 2026; 144DOI:10.1016/j.parkreldis.2026.108208. PMID:41643584. IF:3.400(Q2/3D).
01/03/2026 Potential role of MRI to optimize clinical trial design for progressive supranuclear palsy and corticobasal degeneration
Garcia-Castro, J, Vandevrede, L, Donohue, MC, Vaqué-Alcázar, L, Rubio-Guerra, S, Selma-González, J, Heuer, HW, Morcillo-Nieto, AO, Franquesa, M, Dols-Icardo, O, Bejanin, A, Belbin, O, Fortea, J, Alcolea, D, Carmona-Iragui, M, Abdelnour, C, Barroeta, I, Santos-Santos, M, Saudinós, MBS, Sala, I, Lleó, A, Gorno-Tempini, ML, Mandelli, ML, Raman, R, Wills, AM, Barragan, E, Litvan, I, Boeve, B, Dickerson, B, Grossman, M, Huey, ED, Irwin, DJ, Pantelyat, A, Tartaglia, C, Rojas, JC, Boxer, AL, Illán-Gala, I. Potential role of MRI to optimize clinical trial design for progressive supranuclear palsy and corticobasal degeneration. JPAD-Journal of Prevention of Alzheimers Disease. 2026; 13(3)DOI:10.1016/j.tjpad.2026.100486. PMID:41581260. IF:7.800(Q1/1D).
01/03/2026 Atypical Anti-Glomerular Basement Membrane Disease
Fernández-Lorente, L, Shabaka, A, Mora-Gutiérrez, JM, Caravaca-Fontán, F, Maldonado-Martin, M, Cabello, V, Marco, H, Temprado, A, Rivera, C, Facal, L, Barros, X, Manrique, J, Santos, AP, Fernández-Juárez, G, González, CC. Atypical Anti-Glomerular Basement Membrane Disease. Kidney International Reports. 2026; 11(3)DOI:10.1016/j.ekir.2025.103732. PMID:41584267. IF:5.700(Q1/1D).
01/03/2026 SGLT2 inhibitors in acute heart failure: Intermediate eGFR stratum, potential biases, and applicability in the Emergency Department
Agra Montava, I, Motos Bescos, M, Moline Parejay, A. SGLT2 inhibitors in acute heart failure: Intermediate eGFR stratum, potential biases, and applicability in the Emergency Department. MEDICINA CLINICA. 2026; 166(3)DOI:10.1016/j.medcli.2025.107332. PMID:41604866. IF:2.100(Q2/3D).
01/03/2026 Dose Mapping Using Image Registration for Reirradiation: A Systematic Review
Thiongo, CM, Davey, A, Appelt, A, Day, M, Dupuis, P, Monti, S, Perez-Alija, J, Skopidou, T, Svensson, S, Osorio, EV. Dose Mapping Using Image Registration for Reirradiation: A Systematic Review. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2026; 124(3)DOI:10.1016/j.ijrobp.2025.09.053. PMID:41083027. IF:6.500(Q1/1D).
01/03/2026 Generalized Pustular Psoriasis: Review and Consensus of the Psoriasis Group of the Spanish Academy of Dermatology and Venereology
Puig, L, Carrascosa, JM, Rivera, R, Vilarrasa, E, de la Cueva, P, López-Ferrer, A. Generalized Pustular Psoriasis: Review and Consensus of the Psoriasis Group of the Spanish Academy of Dermatology and Venereology. Actas Dermo-Sifiliograficas. 2026; 117(3)DOI:10.1016/j.ad.2025.104544. PMID:41371399. IF:(Q/D).
01/03/2026 Safety and Efficacy of Bimekizumab in Patients With Moderate-to-Severe Hidradenitis Suppurativa: A Multicenter Retrospective Cohort Study
Mansilla-Polo, M, Pons-Benavent, M, Fernández-Crehuet, P, Vilarrasa, E, Albanell-Fernández, C, Morales-Tedone, E, Rausell-Félix, F, Alcalá-Garcia, R, Matellanes-Palacios, M, Martin-Ezquerra, G, Alfageme, F, Ciudad-Blanco, C, López-Villaescusa, MT, Segura-Palacios, JM, Pascual-Ramirez, JC, Fernández-Diaz, ML, Falkenhain-López, D, Garcia-Gil, M, Agusti-Mejias, A, No-Pérez, N, Naranjo-Guerrero, N, Estenaga-Pérez, A, Garcia-Ruiz, R, Mahiques-Santos, L, Garbayo-Salmons, P, Martorell, A, Escutia-Muñoz, B, Martin-Torregrosa, D, Cuenca-Barrales, C, Paniego, CU, Botella-Estrada, R, Molina-Leyva, A. Safety and Efficacy of Bimekizumab in Patients With Moderate-to-Severe Hidradenitis Suppurativa: A Multicenter Retrospective Cohort Study. Actas Dermo-Sifiliograficas. 2026; 117(3)DOI:10.1016/j.ad.2025.104531. PMID:41354335. IF:(Q/D).
01/03/2026 Anogenital Contact Dermatitis in Spain: A REIDAC Study of Patients Undergoing Patch Testing in 2019-2024
Grau-Pérez, M, Mercader-García, P, Giménez-Arnau, AM, Sanz-Sánchez, T, Ninet, VZ, Guijarro, SC, Miquel, FJM, Salvador, JFS, González-Pérez, R, González, IR, Baldrich, ES, Carrascosa, JM, de Frutos, FJO, Serna, MR, Ortega, MEG, Suárez, CP, Triviño, FJN, Chicharro, P, Andreu, M, Gilo, AS, Rodríguez, JJP, Nieto, MAP, Melé-Ninot, G, Guillén, PS, de la Fuente, EG, Elosua-González, M, Munera-Campos, M, Romero, FT, Descalzo, MA, Borrego, L. Anogenital Contact Dermatitis in Spain: A REIDAC Study of Patients Undergoing Patch Testing in 2019-2024. CONTACT DERMATITIS. 2026; 94(3)DOI:10.1111/cod.70048. PMID:41365615. IF:4.600(Q1/1D).
01/03/2026 Anifrolumab in systemic lupus erythematosus: real-world evidence from a Spanish multicentre cohort of 206 patients and literature review
Calvo-Río, V, Secada-Gómez, C, Gutiérrez, AM, Retuerto-Guerrero, M, Font, J, Casafont-Solé, I, Mayo-Juanatey, A, Sancho, JJA, Freites, D, Hormigos, C, Puñal, NG, Arribas, GG, Sanchez, JRM, García-Valle, A, Ibañez, M, Morillo, FL, Manzanares, AG, Sandoval-Moreno, S, Cortes-Hernandez, J, Sanchez, DP, Lojo, L, Pérez, ECC, Collado, P, Larios, CA, Icardo, LS, Labrador-Sánchez, E, Peralta-Ginés, C, Onaindia, IU, Plaza-Aulestia, N, Malone, MM, de Salazar, JRG, Corteguera, M, Cebrián-Méndez, L, Pages, FAA, Riazuelo, JRL, Canales, MDF, Hernández, MJA, Bufort, MG, Pàmies, A, de Ardanaz, LS, Aguirre-del-Pino, R, Lefler, JAC, Seijas-Lopez, A, Cubero, MDC, Cofiño, ALC, Ortiz-Santamaria, V, Piñeiro, ML, Calvo, CO, Lopez, CA, Urruticoechea-Arana, A, Magallon, BG, Alfaro, AVA, Rodriguez, SL, Olivares, MS, Villar, PL, Brandy-García, AM, Vilamajo, IR, Martos, AG, Lopez, BPM, Urmeneta, GS, Martín, CC, Riera, E, Bejerano, C, Castañeda, S, Blanco, R. Anifrolumab in systemic lupus erythematosus: real-world evidence from a Spanish multicentre cohort of 206 patients and literature review. RMD Open. 2026; 12(1)DOI:10.1136/rmdopen-2025-006549. PMID:41856562. IF:4.700(Q1/1D).
01/03/2026 B cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatment
Agmon-Levin, N, Ignatenko, S, Gordienko, A, Cortés-Hernández, J, Narongroeknawin, P, Romanowska-Próchnicka, K, Shen, N, Ciferska, H, Kodera, M, Cheng-Chung, WJ, Leszczynski, P, Lan, JL, Mysler, E, Wojciechowski, R, Tarr, T, Vishneva, E, Chen, YH, Kaneko, Y, Finzel, S, Hoi, A, Okada, M, Koolvisoot, A, Lee, SS, Lie, D, Kaneko, H, Rojkovich, B, Sun, LY, Zotkin, E, Viallard, JF, López, BPM, Ghanshani, SA, Lau, C, Avrameas, A, Sips, C, Oliver, SJ. B cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatment. ANNALS OF THE RHEUMATIC DISEASES. 2026; 85(3)DOI:10.1016/j.ard.2025.11.015. PMID:41353079. IF:20.600(Q1/1D).
01/03/2026 Switching from Originator Tocilizumab to Biosimilar in Giant Cell Arteritis: Evaluation of Effectiveness and Safety in a Multicenter Cohort of 38 Patients
Loricera, J, Molina-Collada, J, Nieto, JC, Sánchez-Lucas, M, Silva-Díaz, MT, Moya, P, Labrador, E, Ferraz-Amaro, I, Blanco, R. Switching from Originator Tocilizumab to Biosimilar in Giant Cell Arteritis: Evaluation of Effectiveness and Safety in a Multicenter Cohort of 38 Patients. DRUGS & AGING. 2026; 43(3)DOI:10.1007/s40266-026-01281-1. PMID:41714460. IF:3.800(Q2/3D).
01/03/2026 Recommendations for the diagnostic, treatment, and follow-up of late-onset Pompe disease
Dominguez-González, C, Romero, MAB, Eraso, CC, de las Heras, J, Muñoz, EF, Garcia-Campos, O, González, M, Grau, JM, Hernández-Voth, A, Morales, RJ, Hernández, JCL, Martos, ML, López-Padilla, D, Muelas, N, Nascimento, A, Olivé, M, Paradas, C, Fernández, JP, Pascual, SI, Pitarch, I, Sancho, J, Diaz-Manera, J. Recommendations for the diagnostic, treatment, and follow-up of late-onset Pompe disease. NEUROLOGIA. 2026; 41(2)DOI:10.1016/j.nrl.2025.501933. PMID:41453611. IF:3.100(Q2/4D).
01/03/2026 Effect of Rituximab on Neurofilament Levels in CIDP: Results From the CIDPRIT Randomized Trial
Doneddu, PE, Collet-Vidiella, R, Gallo, C, Cocito, D, Manganelli, F, Falzone, Y, Dalla Bella, E, Benedetti, L, Mazzeo, A, Peci, E, Spina, E, Strano, C, Germano, F, Gentile, L, Liberatore, G, Cutellè, C, Bianchi, E, Querol, L, Nobile-Orazio, E. Effect of Rituximab on Neurofilament Levels in CIDP: Results From the CIDPRIT Randomized Trial. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2026; 31(1)DOI:10.1111/jns.70107. PMID:41649095. IF:3.200(Q2/4D).
01/03/2026 Cost Analysis of Immunoglobulin Maintenance Treatment of Patients with Chronic Inflammatory Demyelinating Polyneuropathy in Spain
De Pedro, S, Presa, M, Gamez, J, Fernández, FJG, Querol, L. Cost Analysis of Immunoglobulin Maintenance Treatment of Patients with Chronic Inflammatory Demyelinating Polyneuropathy in Spain. Pharmacoeconomics-Open. 2026; 10(2)DOI:10.1007/s41669-025-00633-8. PMID:41528376. IF:(Q/D).
01/03/2026 Early neurological deterioration before endovascular treatment in patients with mild stroke. MINORCAT-END-EVT study
Font, MA, García-Sánchez, SM, Mengual, JJ, Avellaneda, C, Boned, S, Doncel-Moriano, A, Urra, X, Camps-Renom, P, de la Ossa, NP, Terceño, M, Yugueros, B, Ustrell, X, Purroy, F, Rodríguez-Campello, A, Molina, C, Krupinski, J, Aguirre, GF, Baraldes, M, Jiménez-Fàbrega, X, Salvat-Plana, M, Elosua, R, Abilleira, S, Cardona, P, Gómez-Choco, M. Early neurological deterioration before endovascular treatment in patients with mild stroke. MINORCAT-END-EVT study. Journal of Stroke & Cerebrovascular Diseases. 2026; 35(3)DOI:10.1016/j.jstrokecerebrovasdis.2026.108584. PMID:41679406. IF:1.800(Q3/7D).
01/03/2026 Classification of major depressive disorder using vertex-wise brain sulcal depth, curvature, and thickness with a deep and a shallow learning model
Goya-Maldonado, R, Erwin-Grabner, T, Zeng, LL, Ching, CRK, Aleman, A, Amod, AR, Basgoze, Z, Benedetti, F, Besteher, B, Brosch, K, Bülow, R, Colle, R, Connolly, CG, Corruble, E, Couvy-Duchesne, B, Cullen, K, Dannlowski, U, Davey, CG, Dols, A, Ernsting, J, Evans, JW, Fisch, L, Fuentes-Claramonte, P, Gonul, AS, Gotlib, IH, Grabe, HJ, Groenewold, NA, Grotegerd, D, Hahn, T, Hamilton, JP, Han, LKM, Harrison, B, Ho, TC, Jahanshad, N, Jamieson, AJ, Karuk, A, Kircher, T, Klimes-Dougan, B, Koopowitz, SM, Lancaster, T, Leenings, R, Li, M, Linden, DEJ, Macmaster, FP, Mehler, DMA, Meinert, S, Melloni, E, Mueller, BA, Mwangi, B, Nenadic, I, Ojha, A, Okamoto, Y, Oudega, ML, Penninx, BWJH, Poletti, S, Pomarol-Clotet, E, Portella, MJ, Radua, J, Rodriguez-Cano, E, Sacchet, MD, Salvador, R, Schrantee, A, Sim, K, Soares, JC, Solanes, A, Stein, DJ, Stein, F, Stolicyn, A, Thomopoulos, SI, Toenders, YJ, Uyar-Demir, A, Vieta, E, Vives-Gilabert, Y, Völzke, H, Walter, M, Whalley, HC, Whittle, S, Winter, N, Wittfeld, K, Wright, MJ, Wu, MJ, Yang, TT, Zarate, C, Veltman, DJ, Schmaal, L, Thompson, PM. Classification of major depressive disorder using vertex-wise brain sulcal depth, curvature, and thickness with a deep and a shallow learning model. MOLECULAR PSYCHIATRY. 2026; 31(3)DOI:10.1038/s41380-025-03273-w. PMID:41044403. IF:10.100(Q1/1D).
01/03/2026 Differential Psychological and Social Impact of the COVID-19 Pandemic on Spanish Youth With and Without Non-Suicidal Self-Injury: A Longitudinal Analysis
Schmidt, C, Otero, D, Pascual, JC, Romero, S, Puntí, J, Lara, A, Sintes, A, Méndez, I, Nicolaou, S, Soler, J, Vega, D. Differential Psychological and Social Impact of the COVID-19 Pandemic on Spanish Youth With and Without Non-Suicidal Self-Injury: A Longitudinal Analysis. ACTAS ESPANOLAS DE PSIQUIATRIA. 2026; 54(2)DOI:10.62641/aep.v54i2.2043. PMID:42023465. IF:1.600(Q3/7D).